Today: 3 June 2026
Upcoming Stock Splits This Week: Nasdaq Reverse Splits Pile Up as Booking, Powell and Pashupati Stand Apart

Upcoming Stock Splits This Week: Nasdaq Reverse Splits Pile Up as Booking, Powell and Pashupati Stand Apart

New York, April 13, 2026, 07:03 EDT

Nasdaq names set for reverse splits Monday include NextPlat, MultiSensor AI, Cenntro, and Quince Therapeutics. The split roster for April 13-17 has flipped from last week’s action, which featured forward splits at Booking Holdings and Powell Industries.

The difference is key: forward splits drop the per-share price to make shares more accessible, while reverse splits do the opposite—reducing share count and boosting price, yet leaving market value untouched. Under Nasdaq rules, any stock sitting below $1 for 30 business days straight risks noncompliance, and to get back in line, it needs to log a $1 bid or higher for at least 10 business days.

The gap keeps stretching. Reuters said in November that by the end of October 2025, companies had logged 288 reverse splits—a record—compared to just 53 traditional splits. Almost 80% of those executing reverse splits had market caps under $250 million. Flagstar Bank CIO Brett Mitstifer told Reuters that “slower earnings growth and higher funding costs” are ratcheting up the pressure on smaller players. Christine Short, who leads research at Wall Street Horizon, pointed out that splits may sometimes lift a company’s profile enough to “bring it back into the fold.” Reuters

Nasdaq’s latest corporate-action updates: NextPlat goes 1-for-10 on Monday, MultiSensor AI opts for a 1-for-40 split, and Cenntro moves to 1-for-60. Quince, in a filing dated April 9, also signed off on a 1-for-10 reverse split—its shares are set to begin trading split-adjusted as soon as the market opens Monday.

Reverse splits land Monday for Huachen AI Parking, Skycorp Solar, Akanda, WF Holding, and 707 Cayman. The terms: Akanda goes 1-for-4.5, WF Holding 1-for-5, while both Skycorp and 707 Cayman will trade 1-for-20. Huachen tops the list with the steepest, 1-for-30.

Last week brought a different set of outliers. Booking announced its 25-for-1 forward split took effect April 2, with shares trading on a split-adjusted basis beginning April 6. Powell, which is going with a 3-for-1 split, also planned to launch the new shares April 6. CEO Brett Cope pointed to “continued strong performance and confidence in our growth outlook” as reasons for the move, adding that the split aims to boost access and liquidity. SEC

India’s Pashupati Cotspin set April 17 as the record date for its 10-for-1 stock split, slicing every 10-rupee share into 10 pieces at 1 rupee apiece. The National Stock Exchange of India confirmed the change, saying the new face value kicks in that same day.

Even with shares trading higher, Cenntro’s core business remains unchanged. The company warned there’s “no assurance” it can achieve or keep its Nasdaq listing following the split. Back in March, Quince also acknowledged a Nasdaq notice related to the market value of its securities. Business Wire

Reverse splits may buy issuers more time, but clearing the paperwork is just the start. Nasdaq still wants to see a $1 bid price for at least 10 straight business days within the compliance window. So this week’s moves by companies aren’t a finish line—just the next obstacle.

Latest articles

J-Star Stock Moves Up After Texas Battery Update in Pre-Market

J-Star Stock Moves Up After Texas Battery Update in Pre-Market

3 June 2026
J-Star Holding Co. surged to $1.36 in premarket trading after new disclosures on its proposed $122.5 million Baytown, Texas solid-state battery plant, pushing shares above Nasdaq’s $1 minimum less than a week before a key shareholder vote on a reverse split aimed at regaining compliance.
Legend Biotech jumps 42% as traders look at results from small cancer study

Legend Biotech jumps 42% as traders look at results from small cancer study

3 June 2026
Legend Biotech shares soared 42% to $36.28 after early Phase 1 data showed all six higher-dose patients with relapsed or refractory B-cell non-Hodgkin lymphoma responded to its in vivo CAR-T therapy LB2501, with five complete responses; UBS raised its price target to $49, citing the therapy’s outlook, but the results are early and based on a small group with short follow-up.
T1 Energy Stock Falls Premarket After $32M KORE Battery Deal

T1 Energy Stock Falls Premarket After $32M KORE Battery Deal

3 June 2026
T1 Energy shares fell 1.3% premarket after announcing a $32 million KORE Power acquisition to expand into battery storage and AI data-center infrastructure, just a day after a 15.7% stock surge; Northland initiated coverage with an outperform rating and $16 target, but flagged deal execution and funding as key risks.
UiPath Faces Three-Day Test for AI Stock Rebound

UiPath Shares Back in Focus After AI-Powered Earnings Jump; Eyes Stay on ARR

3 June 2026
UiPath shares retreated to $12.18 premarket after surging 12% on strong Q1 results and first-ever GAAP profitability, as Wall Street remains cautious amid rising competition and mixed analyst targets; investors now weigh if agentic AI adoption can sustain growth or if rivals will pressure recurring revenue.
Palo Alto Networks Reaches All-Time High Ahead of Results as AI Security Rally Drives Wall Street

Palo Alto shares fall premarket even after AI cyber earnings beat

3 June 2026
Palo Alto Networks shares fell in premarket trading to $290.88 despite raising full-year revenue and profit forecasts and posting a 31% jump in quarterly revenue to $3.0 billion, driven by AI-security demand and acquisitions, as investors weigh whether AI-driven growth is already priced in.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Previous Story

US Stock Market Today: Live Updates 12.04.2026

Super Micro Stock Faces Fresh Test as China Probe Casts Shadow Over Nvidia Ties
Next Story

Super Micro Stock Faces Fresh Test as China Probe Casts Shadow Over Nvidia Ties

Go toTop